Home » Topics » Regulatory » Patents

Patents
RSS

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Eli Lilly divulges new MRGPRX1 agonists

Nov. 29, 2021

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Nov. 26, 2021

Merck, Cancer Research Technology divulge YAP1/TEAD interaction inhibitors

Nov. 26, 2021

Takeda Pharmaceutical presents new ABCC2 inhibitors

Nov. 26, 2021

New MAP4K1 inhibitors synthesized at Pfizer

Nov. 26, 2021

Adenosine A2A receptor antagonists identified at Adorx Therapeutics

Nov. 26, 2021

Meiji Seika Pharma divulges histamine H4 receptor antagonists

Nov. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...